FIRST EXTENSION - GRANTED
granted
on 18 Oct 2024
Last Applicant/ Owned by
135 William T Morrissey Blvd
Boston
MA
02125
Serial Number
97646764 filed on 25th Oct 2022
Registration Number
N/A
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
AND-BODY
Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services Biological and chemical agents for scien Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; pharmaceutical preparations, namely, addressable and programmable protein-based therapeutics, for treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97646764
Mark Type
No Service Mark
Attorney Docket Number
No F086320002US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Oct 2024 | SOU EXTENSION 1 GRANTED |
| 18th Oct 2024 | SOU EXTENSION 1 FILED |
| 18th Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Oct 2024 | SOU TEAS EXTENSION RECEIVED |
| 23rd Apr 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 04th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 27th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 07th Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 07th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 20th Jan 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |